Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Analysis in the Rituximab Era

Relapsed and refractory (rel/ref) mantle cell lymphoma (MCL) portends a dismal prognosis. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) represents the only potentially curative therapy in this setting. We analyzed survival outcomes of 29 recipients of non-myeloablative allo-HSCT for...

Descripción completa

Detalles Bibliográficos
Autores principales: Mussetti, Alberto, Devlin, Sean M., Castro-Malaspina, Hugo R, Barker, Juliet N., Giralt, Sergio A., Zelenetz, Andrew D., Sauter, Craig S., Perales, Miguel-Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935530/
https://www.ncbi.nlm.nih.gov/pubmed/26146802
http://dx.doi.org/10.1038/bmt.2015.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935530/
https://www.ncbi.nlm.nih.gov/pubmed/26146802
http://dx.doi.org/10.1038/bmt.2015.156

Ejemplares similares